Dublin, Ireland
16 - 20 May 2015

Satellite Symposia

Satellite symposia offer a great opportunity for you to talk directly to key customer groups. There will be a maximum of four satellite symposia running at any one time and they are open to all attendees. An average of 350 delegates attend each symposium at ECE congresses.

If you are interested in holding a Satellite Symposium at ECE 2015, please contact the ECE 2015 Sales Team at ece2015@endocrinology.org

 

Confirmed sessions

 

HRA Pharma

Sunday 17 May 2015

13:00 – 14:15

WICKLOW HALL 2

What’s recent in Cushing’s syndrome management?

Chairs: Beverly MK Biller (USA) & Massimo Terzolo (Italy)

Welcome and Introduction

Beverly MK Biller (USA) & Massimo Terzolo (Italy)

Update on guidelines for the treatment of Cushing’s syndrome

Lynnette Nieman (USA)

Outcomes of short and long term management of Cushing’s syndrome

Ashley Grossman (UK)

Treatment of severe Cushing’s syndrome

Antoine Tabarin (France)

 

 

Ipsen

Sunday 17 May 2015

13:00 – 14:15

THE LIFFEY A

Achieving tumour control in acromegaly and NET

Chair: Diego Ferone (Italy)

Introduction

Diego Ferone (Italy)

Symptom and tumour control in NET: new findings: An expanding toolkit for symptom control

Matthias Weber (Germany)

Symptom and tumour control in NET: new findings: Evidence for tumour control in NET: the CLARINET trial

Dermot O’Toole (Republic of Ireland)

Panel discussion

Optimising medical therapy in acromegaly for tumour control

John Bevan (UK)

Panel discussion

Chairman’s conclusions

Diego Ferone (Italy)

 

 

Novartis Pharmaceuticals

Monday 18 May 2015

13:00 – 14:15

THE LIFFEY A

Clinical decision-making in acromegaly and Cushing’s disease

Chairs: Mônica Gadelha (Brazil) & Rosario Pivonello (Italy)

Welcome and introduction

Mônica Gadelha (Brazil)

Clinical decision-making in Cushing’s disease

Rosario Pivonello (Italy)

Clinical decision-making in acromegaly

Mônica Gadelha (Brazil)

Concluding remarks

Rosario Pivonello (Italy)

 

 

Shire (ViroPharma)

Monday 18 May 2015

13:00 – 14:15

LIFFEY HALL 2

New horizons in adrenal insufficiency (AI)

Chair: Rob Murray (UK)

Welcome and introduction

Rob Murray (UK)

The burden of illness and current management of AI: exploring real-world data

Rob Murray (UK)

The challenge of glucocorticoid therapy in patients with AI: are we doing the right thing?

Gudmundur Johannsson (Sweden)

Improved cell-mediated immune function in patients with AI following dual-release hydrocortisone 

Andrea Isidori (Italy)

Panel discussion and Q&A

All

Summary and close

Rob Murray (UK)